Biopharma

Herbal medicinal product: Prunus avium peduncleArray,Ar...

Herbal medicinal product: Prunus avium peduncleArray,Array, D: Draft under discu...

BioCity’s ETA antagonist reduces proteinuria in phase 2...

BioCity Biopharma’s selective endothelin receptor type A antagonist has reduced ...

Entrada's 2-year ordeal ends as FDA lifts hold on DMD drug

Entrada Therapeutics is finally able to get its Duchenne muscular dystrophy cand...

STAT+: Under siege after a tragedy, UnitedHealth grappl...

Heightened security at UnitedHealth Group's Minnesota headquarters in the wake o...

Opinion: ‘Ultra-processed food’ is too broad a term to ...

Legislatures, governors, government agencies, and plaintiff attorneys are taking...

Covid, inflation, and Supreme Court blamed for steep dr...

Native American leaders were taken aback to see 22% fewer American Indian or Ala...

Opinion: What academic research could learn from colleg...

Just as college sports have had to change, so does basic science research at uni...

STAT+: Some NIH study sections will resume reviewing gr...

While some NIH study sections will resume, advisory council meetings, which make...

STAT+: J&J sues Samsung over a contract breach for a St...

As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S...

FDA brings back some fired device office staff

An industry source said “most, if not all” of the people at CDRH who were recent...

Depression Risk Lower With GLP-1 Receptor Agonists Vers...

MONDAY, Feb. 24, 2025 -- For older adults with type 2 diabetes (T2D), use of gl...

2.3 Million New Female Breast Cancer Cases Seen Globall...

MONDAY, Feb. 24, 2025 -- In 2022, there were 2.3 million new breast cancer case...

Deerfield sues to stop Alcon’s 'unrelenting campaign' t...

As Alcon Research seeks to block investee Aurion Biotech from listing on the New...

In letter to RFK Jr., Democrats flag threats to drug re...

HHS secretary Robert F. Kennedy Jr. has been on the receiving end of two heated ...

STAT+: UnitedHealth buyouts, and drug pricing spreads

This week in health care new: UnitedHealth works to reduce staff, Trump's CMS st...

Pfizer to test Summit's white-hot bispecific with ADCs

Pfizer has teamed up with Summit Therapeutics to assess whether one of the indus...

Antibodies stop tissue damage and reduce virus levels i...

Researchers studying a deadly virus discovered a key protein behind its lethalit...

Regeneron gene therapy improves hearing in 10 children ...

Regeneron’s investigational gene therapy has been tied to notable hearing improv...

STAT+: Federal judge extends restraining order on Trump...

Judge Angel Kelley kept in place an order blocking the Trump administration from...

STAT+: Pfizer CEO Albert Bourla inflicts injury on his ...

The hiring of a former top FDA official amplifies "revolving door" criticism at ...

India’s Granules makes $22M play for Senn Chemicals to ...

Granules shelled out a reported 20 million Swiss francs ($22.3 million) to acqui...

Mirum drug for rare genetic disease gains FDA approval

Mirum gained the drug, which it will sell as Ctexli for adults with cerebrotendi...

Summit partners with Pfizer to study bispecific, ADC co...

The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug con...

Increased Odds of Leaving ED Before Medically Advised T...

MONDAY, Feb. 24, 2025 -- In the United States, the COVID-19 pandemic was associ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.